Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Keyphrases

• Non-covalent 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 100%
• Open Science 100%
• Main Protease Inhibitor 100%
• Drug Discovery 66%
• Crowdsourcing 66%
• Main Protease 66%
• Structural Chemistry 33%
• High-throughput 33%
• Structural Plasticity 33%
• Knowledge Base 33%
• Structural Biology 33%
• Machine Learning 33%
• Structure-activity Relationship 33%
• Coronavirus Disease (COVID) 33%
• Crystallographic Data 33%
• Exascale 33%
• Biochemical Activity 33%
• X-ray Structure 33%
• Open Structure 33%
• Chemotype 33%
• Molecular Simulation 33%
• Activity Data 33%
• Intellectual Property 33%
• Assay Data 33%
• Moonshot 33%
• Extensive Structure 33%
• Compound Design 33%
• Lead-like 33%
• Free Knowledge 33%
• Inhibitor Scaffold 33%
• Non-peptidic Inhibitors 33%

Biochemistry, Genetics and Molecular Biology

• SARS Coronavirus 100%
• Protease Inhibitor 100%
• Protease 66%
• Drug Development 66%
• Knowledge Base 33%
• Structure Activity Relation 33%

Chemistry

• Drug Discovery 100%
• Chemistry 50%
• Base 50%
• Structure-Activity Relationship 50%
• Biochemical Activity 50%